Does this patient have bacterial peritonitis or portal hypertension? How do i perform a paracentesis and analyze the results?

JAMA

Volumn 299, Issue 10, 2008, Pages 1166-1178

  Wong, Camilla L ^a   Holroyd Leduc, Jayna ^b,d   Thorpe, Kevin E ^b,c   Straus, Sharon E ^b,d,e  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF CALGARY   (Canada)

^e FOOTHILLS HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; PLASMA SUBSTITUTE; SERUM ALBUMIN;

ASCITES FLUID; BACTERIAL PERITONITIS; BRAIN DISEASE; CHEMICAL ANALYSIS; DEATH; DIAGNOSTIC ACCURACY; FIBRINOLYSIS; HEALTH HAZARD; HUMAN; HYPONATREMIA; LEUKOCYTE COUNT; PARACENTESIS; PERFORATION; PH; PORTAL HYPERTENSION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; ULTRASOUND; BACTERIAL INFECTION; BLOOD; CHEMISTRY; CYTOLOGY; DIFFERENTIAL DIAGNOSIS; DRUG CONTRAINDICATION; METHODOLOGY; MICROBIOLOGY; NEUTROPHIL; PERITONEAL CAVITY; PERITONITIS;

ASCITIC FLUID; BACTERIAL INFECTIONS; DIAGNOSIS, DIFFERENTIAL; HUMANS; HYDROGEN-ION CONCENTRATION; HYPERTENSION, PORTAL; LEUKOCYTE COUNT; NEUTROPHILS; PARACENTESIS; PERITONEAL CAVITY; PERITONITIS; SERUM ALBUMIN;

EID: 40749083565     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.299.10.1166     Document Type: Review

References (118)

1. Williams JW Jr, Simel DL. The rational clinical examination: does this patient have ascites? JAMA. 1992;267(19):2645-2648.
2. Ginés P, Quintero E, Arroyo V, et al. Compensated cirrhosis. Hepatology. 1987;7(1):122-128.
3. Krencker E. Bacterium coli commune als sepsiserreger in 2 fällen von abdominalerkrankungen. Munchen Med Wschr. 1907;54:2095.
4. Menetrier P, Duval R. Peritonite a pneumocoques a forme ascitique chez une malade atteinte de cirrhose atrophique. Bull Mem Soc Med Hop Paris. 1906;22:208.
5. Pinzello G, Simonetti RG, Craxi A, Di Piazza S, Spano C, Pagliaro L. Spontaneous bacterial peritonitis. Hepatology. 1983;3(4):545-549.
6. Correia JP, Conn HO. Spontaneous bacterial peritonitis in cirrhosis: endemic or epidemic? Med Clin North Am. 1975;59(4):963-981.
7. Thuluvath PJ, Morss S, Thompson R. Spontaneous bacterial peritonitis-in-hospital mortality, predictors of survival, and health care costs from 1988 to 1998. Am J Gastroenterol. 2001;96(4):1232-1236.
8. Grabau CM, Crago SF, Hoff LK, et al. Performance standards for therapeutic abdominal paracentesis. Hepatology. 2004;40(2):484-488.
9. Lin CH, Shih FY, Ma MH, Chiang WC, Yang CW, Ko PC. Should bleeding tendency deter abdominal paracentesis? Dig Liver Dis. 2005;37(12):946-951.
10. Mallory A, Schaefer JW. Complications of diagnostic paracentesis in patients with liver disease. JAMA. 1978;239(7):628-630.
11. McVay PA, Toy PT. Lack of increased bleeding after paracentesis and thoracentesis in patients with mild coagulation abnormalities. Transfusion. 1991;31(2):164-171.
12. Pache I, Bilodeau M. Severe haemorrhage following abdominal paracentesis for ascites in patients with liver disease. Aliment Pharmacol Ther. 2005; 21(5):525-529.
13. Runyon BA. Paracentesis of ascitic fluid. Arch Intern Med. 1986;146(11):2259-2261.
14. Shaheen NJ, Grimm IS. Comparison of the caldwell needle/cannula with angiocath needle in large volume paracentesis. Am J Gastroenterol. 1996;91(9):1731-1733.
15. Webster ST, Brown KL, Lucey MR, Nostrant TT. Hemorrhagic complications of large volume abdominal paracentesis. Am J Gastroenterol. 1996;91(2):366-368.
16. Duggal P, Farah KF, Anghel G, et al. Safety of paracentesis in inpatients. Clin Nephrol. 2006;66(3):171-176.
17. Koffel KK, Reed JS. The technique of abdominal paracentesis. J Crit Illn. 1986;1:45-50.
18. Sakai H, Sheer TA, Mendler MH, Runyon BA. Choosing the location for non-image guided abdominal paracentesis. Liver Int. 2005;25(5):984-986.
19. Bard C, Lafortune M, Breton G. Ascites: Ultrasound guidance or blind paracentesis? CMAJ. 1986;135(3):209-210.
20. Nazeer SR, Dewbre H, Miller AH. Ultrasound-assisted paracentesis performed by emergency physicians vs the traditional technique. Am J Emerg Med. 2005;23(3):363-367.
21. Goldberg BB, Goodman GA, Clearfield HR. Evaluation of ascites by ultrasound. Radiology. 1970;96(1):15-22.
22. Boccia S, Rollo V, Accorsi L, Macario F, Merighi A, Gullini S. Paracentesis: a new needle for an old technique. Endoscopy. 1991;23(2):83-84.
23. Runyon BA, Antillon MR, Akriviadis EA, McHutchison JG. Bedside inoculation of blood culture bottles with ascitic fluid is superior to delayed inoculation in the detection of spontaneous bacterial peritonitis. J Clin Microbiol. 1990;28(12):2811-2812.
24. Simonetti RG, Gluud C, Milazzo G, Pagliaro L. Albumin and other plasma expanders for paracentesis treatment of ascites in cirrhotic patients (protocol). Cochrane Database Syst Rev. 2003;(1):CD004039. DOI: 10.1002/14651858.CD004039.
25. Acharya SK, Balwinder S, Padhee AK, Nijhawan S, Tandon BN. Large volume paracentesis and intravenous dextran to treat tense ascites. J Clin Gastroenterol. 1992;14(1):31-35.
26. Choi CH, Ahn SH, Kim DY, et al. Long-term clinical outcome of large volume paracentesis with intravenous albumin in patients with spontaneous bacterial peritonitis: a randomized prospective study. J Gastroenterol Hepatol. 2005;20(8):1215-1222.
27. Solà R, Vila MC, Andreu M, et al. Total paracentesis with dextran 40 vs diuretics in the treatment of ascites in cirrhosis. J Hepatol. 1994;20(2):282-288.
28. Graziotto A, Rossaro L, Inturri P, Salvagnini M. Reinfusion of concentrated ascitic fluid versus total paracentesis. Dig Dis Sci. 1997;42(8):1708-1714.
29. Bruno S, Borzio M, Romagnoni M, et al. Comparison of spontaneous ascites filtration and reinfusion with total paracentesis with intravenous albumin infusion in cirrhotic patients with tense ascites. BMJ. 1992;304(6843):1655-1658.
30. Borzio M, Romagnoni M, Sorgato G, et al. A simple method for ascites concentration and reinfusion. Dig Dis Sci. 1995;40(5):1054-1059.
31. Bernardi M, Rimondi A, Gasbarrini A, et al. Ascites apheresis, concentration and reinfusion for the treatment of massive or refractory ascites in cirrhosis. J Hepatol. 1994;20(2):289-295.
32. Singh V, Kumar B, Nain CK, et al. Noradrenaline and albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized pilot study. J Intern Med. 2006;260(1):62-68.
33. Singh V, Kumar R, Nain CK, Singh B, Sharma AK. Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study. J Gastroenterol Hepatol. 2006;21(1 Pt 2):303-307.
34. Moreau R, Valla DC, Durand-Zaleski I, et al. Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid. Liver Int. 2006;26(1):46-54.
35. Antillon MR, Runyon BA. Postparacentesis plasma expansion prevents asymptomatic laboratory abnormalities, but does it have any impact on morbidity or mortality? Gastroenterology. 1991;101(5):1455-1457.
36. Arroyo V, Colmenero J. Use of albumin in the management of patients with decompensated cirrhosis. Dig Liver Dis. 2003;35(9):668-672.
37. Ascione A, Burroughs AK. Paracentesis for ascites in cirrhotic patients. Gastroenterol Int. 1990;3:120-123.
38. Burroughs AK. Is the use of albumin of value in cirrhosis? Dig Liver Dis. 2003;35(9):664-667.
39. Cabrera J, Inglada L, Quintero E, et al. Largevolume paracentesis and intravenous saline. Hepatology. 1991;14(6):1025-1028.
40. Forouzandeh B, Konicek F, Sheagren JN. Large-volume paracentesis in the treatment of cirrhotic patients with refractory ascites. J Clin Gastroenterol. 1996;22(3):207-210.
41. Ginès P, Guevara M, De Las Heras D, Arroyo V. Review article: albumin for circulatory support in patients with cirrhosis. Aliment Pharmacol Ther. 2002;16(suppl 5):24-31.
42. Kellerman PS, Linas SL. Large-volume paracentesis in treatment of ascites. Ann Intern Med. 1990;112(12):889-891.
43. Laffi G, Gentilini P, Romanelli RG, La Villa G. Is the use of albumin of value in the treatment of ascites in cirrhosis? Dig Liver Dis. 2003;35(9):660-663.
44. Maor Y. The use of albumin in patients with decompensated cirrhosis: the case in favor. Isr Med Assoc J. 2005;7(2):115-118.
45. Patel AS, Gordon SC. Large-volume paracentesis in outpatients. Ann Intern Med. 1989;110(4):325-326.
46. Peltekian KM, Wong F, Liu PP, Logan AG, Sherman M, Blendis LM. Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites. Am J Gastroenterol. 1997;92(3):394-399.
47. Pinto PC, Amerian J, Reynolds TB. Largevolume paracentesis in nonedematous patients with tense ascites. Hepatology. 1988;8(2):207-210.
48. Salerno F, Badalamenti S, Incerti P, et al. Paracentesis: a re-evaluated procedure in the management of cirrhotic patients with ascites. Ital J Gastroenterol. 1990;22(1):44-49.
49. Schmidt LE, Ring-Larsen H. The use of albumin infusion in decompensated cirrhosis of the liver. Ugeskr Laeger. 2002;164(9):1196-1202.
50. Terg R, Berreta J, Abecasis R, Romero G, Boerr L. Dextran administration avoids hemodynamic changes following paracentesis in cirrhotic patients: a safe and inexpensive option. Dig Dis Sci. 1992;37(1):79-83.
51. Vila MC, Coll S, Sola R, Andreu M, Gana J, Marquez J. Total paracentesis in cirrhotic patients with tense ascites and dilutional hyponatremia. Am J Gastroenterol. 1999;94(8):2219-2223.
52. Altman C, Bernard B, Roulot D, Vitte RL, Ink O. Randomized comparative multicenter study of hydroxyethyl starch versus albumin as a plasma expander in cirrhotic patients with tense ascites treated with paracentesis. Eur J Gastroenterol Hepatol. 1998;10(1):5-10.
53. Fassio E, Terg R, Landeira G, et al. Paracentesis with dextran 70 vs. paracentesis with albumin in cirrhosis with tense ascites. J Hepatol. 1992;14(2-3):310-316.
54. García-Compeán D, Zacarías Villarreal J, Bahena Cuevas H, et al. Total therapeutic paracentesis (TTP) with and without intravenous albumin in the treatment of cirrhotic tense ascites. Liver. 1993;13(5):233-238.
55. Ginès P, Tito L, Arroyo V, et al. Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. Gastroenterology. 1988;94(6):1493-1502.
56. Ginès A, Fernández-Esparrach G, Monescillo A, et al. Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis. Gastroenterology. 1996;111(4):1002-1010.
57. Planas R, Ginès P, Arroyo V, et al. Dextran-70 versus albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis. Gastroenterology. 1990;99(6):1736-1744.
58. Salerno F, Badalamenti S, Lorenzano E, Moser P, Incerti P. Randomized comparative study of hemaccel vs albumin infusion after total paracentesis in cirrhotic patients with refractory ascites. Hepatology. 1991;13(4):707-713.
59. Sola-Vera J, Minana J, Ricart E, et al. Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites. Hepatology. 2003;37(5):1147-1153.
60. Zhao J, Yuan C, Wang D. Mannitolum infusion on cirrhotic patients with tense ascites treated by paracentesis. Chin Med J (Engl). 2000;113(1):27-30.
61. Bar-Meir S, Lerner E, Conn HO. Analysis of ascitic fluid in cirrhosis. Dig Dis Sci. 1979;24(2):136-144.
62. Jones SR. The absolute granulocyte count in ascites fluid. West J Med. 1977;126(5):344-346.
63. Lee HH, Carlson RW, Bull DM. Early diagnosis of spontaneous bacterial peritonitis. Infection. 1987;15(4):232-236.
64. Mbopi Kéou FX, Bloch F, Buu Hoi A, et al. Spontaneous peritonitis in cirrhotic hospital in-patients. Q J Med. 1992;83(301):401-407.
65. Miros M, Kerlin P. Spontaneous bacterial peritonitis and the ascitic fluid polymorph count. Aust N Z J Med. 1988;18:143-147.
66. Antillon MR, Runyon BA. Effect of marked peripheral leukocytosis on the leukocyte count in ascites. Arch Intern Med. 1991;151(3):509-510.
67. Mehrotra MP, Saxena KK, Mathur DC. Etiological diagnosis of ascites. Indian J Med Res. 1972;60(7):1089-1100.
68. Attali P, Turner K, Pelletier G, Ink O, Etienne JP. pH of ascitic fluid. Gastroenterology. 1986;90(5 pt 1):1255-1260.
69. Boyer TD, Kahn AM, Reynolds TB. Diagnostic value of ascitic fluid lactic dehydrogenase, protein, and WBC levels. Arch Intern Med. 1978;138(7):1103-1105.
70. Garcia-Tsao G, Conn HO, Lerner E. The diagnosis of bacterial peritonitis. Hepatology. 1985;5(1):91-96.
71. Scemama-Clergue J, Doutrellot-Philippon C, Metreau JM, Teisseire B, Capron D, Dhumeaux D. Ascitic fluid pH in alcoholic cirrhosis. Gut. 1985;26(4):332-335.
72. Lee MY, Wang SS, Lu CW, et al. Diagnostic parameters for spontaneous bacterial peritonitis in hepatitis B-related cirrhosis. Chin J Surg. 1994;53(2):71-76.
73. Runyon BA, Hoefs JC, Morgan TR. Ascitic fluid analysis in malignancy-related ascites. Hepatology. 1988;8(5):1104-1109.
74. Albillos A, Cuervas-Mons V, Millan I, et al. Ascitic fluid polymorphonuclear cell count and serum to ascites albumin gradient in the diagnosis of bacterial peritonitis. Gastroenterology. 1990;98(1):134-140.
75. Almdal TP, Skinhoj P. Spontaneous bacterial peritonitis in cirrhosis. Scand J Gastroenterol. 1987;22(3):295-300.
76. Colli A, Cocciolo M, Riva C, et al. Ascitic fluid analysis in hepatocellular carcinoma. Cancer. 1993;72(3):677-682.
77. el-Touny M, Osman L, Abd-el Hamid T, Sabbour MS. Re-evaluation of the value of ascitic fluid pH lactate dehydrogenase and total proteins in the diagnosis of spontaneous bacterial peritonitis (SBP). J Trop Med Hyg. 1989;92(1):6-9.
78. Gitlin N, Stauffer JL, Silvestri RC. The pH of ascitic fluid in the diagnosis of spontaneous bacterial peritonitis in alcoholic cirrhosis. Hepatology. 1982;2(4):408-411.
79. Kao HW, Reynolds TB. The diagnosis of spontaneous bacterial peritonitis in alcoholic cirrhosis. Hepatology. 1983;3(2):275-276.
80. Kline MM, McCallum RW, Guth PH. The clinical value of ascitic fluid culture and leukocyte count studies in alcoholic cirrhosis. Gastroenterology. 1976;70(3):408-412.
81. Rai RR, Acharya SK, Kambam V, Gandhi BM, Tandon BN. Evaluation of ascitic fluid polymorphonuclear count & ascitic fluid pH in early diagnosis of spontaneous bacterial peritonitis. Indian J Med Res. 1988;87:600-604.
82. Runyon BA, Antillon MR. Ascitic fluid pH and lactate. Hepatology. 1991;13(5):929-935.
83. Stassen WN, McCullough AJ, Bacon BR, et al. Immediate diagnostic criteria for bacterial infection of ascitic fluid. Gastroenterology. 1986;90(5 pt 1):1247-1254.
84. Storgaard JS, Svendsen JH, Hegnhoj J, Krintel JJ, Nielsen PB. Incidence of spontaneous bacterial peritonitis in patients with ascites. Liver. 1991;11(4):248-252.
85. Wang SS, Lu CW, Chao Y, et al. Malignancy-related ascites. J Hepatol. 1994;20(1):79-84.
86. Wilson JA, Suguitan EA, Cassidy WA, Parker RH, Chan CH. Characteristics of ascitic fluid in the alcoholic cirrhotic. Dig Dis Sci. 1979;24(8):645-648.
87. Yang CY, Liaw YF, Chu CM, Sheen IS. White count, pH and lactate in ascites in the diagnosis of spontaneous bacterial peritonitis. Hepatology. 1985;5(1):85-90.
88. Rimola A, Garcia-Tsao G, Navasa M, et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis. J Hepatol. 2000;32(1):142-153.
89. Runyon BA; Practice Guidelines Committee; American Association for the Study of Liver Diseases (AASLD). Management of adult patients with ascites due to cirrhosis. Hepatology. 2004;39(3):841-856.
90. Sánchez-Lombraña JL, de la Vega J, Fernandez E, et al. Tuberculous peritonitis. Scand J Gastroenterol. 1995;30(1):87-91.
91. Rana SV, Babu SG, Kocchar R. Usefulness of ascitic fluid cholesterol as a marker for malignant ascites. Med Sci Monit. 2005;11(3):CR136-CR142.
92. Attali P, Pelletier G, Douard H, Buffet C, Etienne JP. Ascitic pH and infection in alcoholic cirrhosis. Gastroenterol Clin Biol. 1984;8(6-7):518-522.
93. Conn HO. Acidic ascitic fluid. Hepatology. 1982;2(4):507-510.
94. Reynolds TB. Rapid presumptive diagnosis of spontaneous bacterial peritonitis. Gastroenterology. 1986;90(5 pt 1):1294-1297.
95. Bansal S, Kaur K, Bansal AK. Diagnosing ascitic etiology on a biochemical basis. Hepatogastroenterology. 1998;45(23):1673-1677.
96. Dittrich S, Yordi LM, de Mattos AA. The value of serum-ascites albumin gradient for the determination of portal hypertension in the diagnosis of ascites. Hepatogastroenterology. 2001;48(37):166-168.
97. Hoefs JC. Serum protein concentration and portal pressure determine the ascitic fluid protein concentration in patients with chronic liver disease. J Lab Clin Med. 1983;102(2):260-273.
98. Kajani MA, Yoo YK, Alexander JA, et al. Serumascites albumin gradients in nonalcoholic liver disease. Dig Dis Sci. 1990;35(1):33-37.
99. Runyon BA, Montano AA, Akriviadis EA, Antillon MR, Irving MA, McHutchison JG. The serumascites albumin gradient is superior to the exudatetransudate concept in the differential diagnosis of ascites. Ann Intern Med. 1992;117(3):215-220.
100. Akriviadis EA, Kapnias D, Hadjigavriel M, Mitsiou A, Goulis J. Serum/ascites albumin gradient. Scand J Gastroenterol. 1996;31(8):814-817.
101. Chen SJ, Wang SS, Lu CW, et al. Clinical value of tumour markers and serum-ascites albumin gradient in the diagnosis of malignancy-related ascites. J Gastroenterol Hepatol. 1994;9(4):396-400.
102. Goyal AK, Goyal SK, Pokharna DS, Sharma SK. Differential diagnosis of ascitic fluid: evaluation and comparison of various biochemical criteria with a special reference to serum ascites albumin concentration gradient and its relation to portal pressure. Trop Gastroenterol. 1989;10(1):51-55.
103. Gupta R, Misra SP, Dwivedi M, Misra V, Kumar S, Gupta SC. Diagnosing ascites. J Gastroenterol Hepatol. 1995;10(3):295-299.
104. Mauer K, Manzione NC. Usefulness of serumascites albumin difference in separating transudative from exudative ascites. another look. Dig Dis Sci. 1988;33(10):1208-1212.
105. Paré P, Talbot J, Hoefs JC. Serum-ascites albumin concentration gradient. Gastroenterology. 1983;85(2):240-244.
106. Cakaloglu Y, Okten A, Yalcin S. Serum-ascites albumin concentration gradient (A-GRAD) in the prediction of portal hypertension in ascitic patients. Gastroenterology. 1991;100(5 Pt 1):1484-1485.
107. Rubin E. Serum-ascitic fluid albumin gradient, portal hypertension, and ascites. Mayo Clin Proc. 1997;72(5):487.
108. Lee CM, Changchien CS, Shyu WC, Liaw YF. Serum-ascites albumin concentration gradient and ascites fibronectin in the diagnosis of malignant ascites. Cancer. 1992;70(8):2057-2060.
109. Prieto M, Gomez-Lechon MJ, Hoyos M, Castell JV, Carrasco D, Berenguer J. Diagnosis of malignant ascites. Dig Dis Sci. 1988;33(7):833-838.
110. Al-Knawy BA. Etiology of ascites and the diagnostic value of serum-ascites albumin gradient in nonalcohol liver disease. Ann Saudi Med. 1997;17(1):26-28.
111. American Board of Internal Medicine. Become certified by ABIM. http://www.abim.org/certification/. Accessed.
112. Wigton RS, Blank LL, Nicolas JA, Tape TG. Procedural skills training in internal medicine residencies. a survey of program directors. Ann Intern Med. 1989;111(11):932-938.
113. Hicks CM, Gonzalez R, Morton MT, Gibbons RV, Wigton RS, Anderson RJ. Procedural experience and comfort level in internal medicine trainees. J Gen Intern Med. 2000;15(10):716-722.
114. Wickstrom GC, Kolar MM, Keyserling TC, et al. Confidence of graduating internal medicine residents to perform ambulatory procedures. J Gen Intern Med. 2000;15(6):361-365.
115. Oxentenko AS, Ebbert JO, Ward LE, Pankratz VS, Wood KE. A multidimensional workshop using human cadavers to teach bedside procedures. Teach Learn Med. 2003;15(2):127-130.
116. Powers LR, Draeger SK. Using workshops to teach residents primary care procedures. Acad Med. 1992;67(11):743-745.
117. Weaver ME, Kyrouac JP, Frank S, Rabinovich S. A cadaver workshop to teach medical procedures. Med Educ. 1986;20(5):407-409.
118. Smith CC, Gordon CE, Feller-Kopman D, et al. Creation of an innovative inpatient medical procedure service and a method to evaluate house staff competency. J Gen Intern Med. 2004;19(5 pt 2):510-513.